Skip to main content
OpenTrials
Completed

NCT Number: NCT04251273

Text Message Quit Vaping Intervention for Young Adults

This research study, conducted by Truth Initiative, will help us learn how text messaging can help young adults between 18 and 24 years of age quit vaping.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Cessation Behavior Health Behavior Tobacco Use Cessation

Age range

18 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Truth Initiative

Washington D.C., District of Columbia, 20001, United States

About this study

The Quit Vaping Study (QVS)'s primary aim is to conduct a fully powered comparative effectiveness trial to evaluate the effectiveness of a quit vaping text message program in promoting abstinence from e-cigarettes among young users aged 18-24. This study is a 2-arm randomized controlled trial conducted among young users aged 18-24 recruited through online channels. Participants will be randomized to a quit vaping text message intervention or to an assessment-only control condition and followed for 7 months to roughly correspond to 6-months post-treatment. The secondary aim is to examine potential mediators of program effectiveness, including treatment engagement and changes in self-efficacy and perceived social support for quitting.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-24
  • Past 30-day use of e-cigarettes containing nicotine
  • Interest in quitting e-cigarette use in the next 30 days
  • US residence

Exclusion criteria

  • Failure to confirm mobile number after initial sign-up

Treatment and study plan

This is Quitting

Other

Text message-based intervention for quit vaping support.

Assessment only control

Other

Assessment only

Primary outcomes

  1. Number of Participants With Self-reported 30-day Point Prevalence Abstinence (ITT)

    Time frame: 7 months post enrollment

    Number of participant who responded "No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is all randomized participants.

Secondary outcomes

  1. Number of Participants With Self-reported 30-day Point Prevalence Abstinence (Responder Only)

    Time frame: 7 month post enrollment

    Number of participants with who responded 'No" to the question "In the past 30 days, did you vape at all, even a puff of someone else's?" Denominator is participants with responses only.

  2. Number of Participants With Self-reported 7-day Point Prevalence Abstinence (ITT)

    Time frame: 7 months post enrollment

    Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is all randomized participants.

  3. Number of Participants With Self-reported 7-day Point Prevalence Abstinence (Responder Only)

    Time frame: 7 months post enrollment

    Number of participants who responded "No" to the question "Have you used any vape, even one puff, in the past 7 days?" Denominator is those who responded to the question only.

Sponsors and collaborators

Lead sponsor

Truth Initiative

Other

Registry information

Official study title

A Randomized Trial of a Text Message Quit Vaping Intervention for Young Adults

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Jan 31, 2020
Registry last updated
Jul 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.